Biogen BIIB
NASDAQ BIIB
$217.15 +1.72 (+0.80%)
As of: Sep 11, 2026 · 3:59 PM EDT

Biogen (BIIB) Dividends Paid - Common (QoQ) (2010 - 2020)

Analysis

Biogen (BIIB) Dividends Paid - Common (QoQ) (2010 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Insmed 28.06 Bn 26.90 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -99.86%
Dec 31, 2018 75.00%
Sep 30, 2018 -104.00%
Dec 31, 2011 -79.20%
Dec 31, 2010 98.81%
Sep 30, 2010 701.82%
Jun 30, 2010 -87.76%
Mar 31, 2010 89.43%